Teva Announces Launch of Generic Xeloda® Tablets 150 MG and 500 MG in the United States
Widening investment-grade credit spreads and rising interest rates lead to losses.
Med-tech multinationals look to the East for growth in China.
Many developed-country health-care firms have deep roots in emerging markets and can be a good way to gain exposure, says Morningstar's Damien Conover.
The corporate bond market will probably struggle to return much above break-even in 2014.
Health-care exchanges provide the biggest uncertainty going into 2014.
Health-care stocks are on a tear as demand slowly returns.
Plus, a top executive bolts from eBay, Brazilian telcos get cheap, and more.